Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. eDrugstore
WARNING LETTER
•eDrugstore•August 31, 2025

eDrugstore – FDA Warning Letter, Aug 31, 2025

Record Details

The FDA issued a warning letter to eDrugstore, located at 5801 S. McClintock Drive, Suite 107, Tempe, AZ, on September 9, 2025, following a review of their website in August 2025. The FDA identified that eDrugstore"s website offers compounded drug products, including tirzepatide, with claims that are false or misleading under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act (FDCA). These claims suggest that the compounded drugs are equivalent to FDA-approved products, which they are not, resulting in the misbranding of these products.

The regulatory framework cited includes sections 502(a), 502(bb), and 301(a) of the FDCA, which address misbranding and the introduction of such products into interstate commerce. The FDA requires eDrugstore to take immediate corrective actions, including ceasing the use of misleading language and ensuring compliance with federal law. The company must respond within 15 working days, detailing the steps taken to rectify the violations and prevent recurrence. Failure to comply may lead to legal actions such as seizure or injunction.

eDrugstore is advised to provide a written response to the Office of Compounding Quality and Compliance, including documentation of corrective measures. If eDrugstore believes their products are compliant, they must provide supporting information. Non-compliance could result in further regulatory actions, including notifying foreign regulatory bodies if applicable.

Company
eDrugstore
Inspection date
August 31, 2025
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • George Tidmarsh (Director)
View Company Profile

ID · 8e988f3a-5671-4d67-a528-55ba57031749

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 352(bb)21 U.S.C. 331(c)21 U.S.C. 321(p)FD&C Act 502(a)FD&C Act 301(a)FD&C Act 201(g)FD&C Act 502(b)21.U.S.C. 331(a)21 U.S.C. 352(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore eDrugstore
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.